middl
east
respiratori
syndrom
coronaviru
merscov
caus
sever
fatal
acut
respiratori
diseas
human
remain
endem
middl
east
sinc
first
identifi
current
approv
vaccin
therapi
avail
merscov
studi
evalu
parainfluenza
viru
base
vaccin
express
merscov
envelop
spike
protein
merss
human
knockin
congen
mous
model
ki
follow
singledos
intranas
immun
induc
neutral
antibodi
robust
cell
respons
ki
mice
singl
intranas
administr
pfu
provid
complet
protect
lethal
challeng
mouseadapt
merscov
mer
improv
viru
clearanc
lung
comparison
singledos
intramuscular
immun
pfu
uvinactiv
mer
mix
imject
alum
provid
protect
immun
mice
intriguingli
influx
eosinophil
observ
lung
mice
immun
inactiv
merscov
suggest
hypersensitivitytyp
respons
overal
studi
indic
promis
effect
vaccin
candid
merscov
infect
import
merscov
caus
lethal
infect
human
vaccin
work
demonstr
promis
vector
develop
mer
vaccin
furthermor
success
mer
vaccin
employ
develop
vaccin
emerg
cov
caus
iddl
east
respiratori
syndrom
mer
emerg
signific
ill
saudi
arabian
peninsula
caus
agent
identifi
novel
coronaviru
cov
merscov
mer
high
mortal
rate
associ
sever
lung
diseas
advanc
acut
respiratori
distress
syndrom
ard
merscov
similarli
sarscov
caus
similar
epidem
global
caus
concern
due
high
fatal
rate
epidemiolog
studi
establish
merscov
zoonot
origin
transmiss
occur
dromedari
camel
arabian
peninsula
spread
camel
peopl
document
well
persontoperson
spread
among
health
care
worker
hospit
set
date
merscov
spread
countri
caus
death
confirm
case
februari
world
health
organ
includ
larg
travelrel
outbreak
south
korea
merscov
envelop
positivestrand
rna
viru
whose
entri
target
cell
mediat
viral
envelop
protein
protein
consist
subunit
respons
bind
viru
receptor
dipeptidyl
peptidas
via
receptorbind
domain
rbd
subunit
mediat
membran
fusion
thu
protein
particularli
rbd
import
target
merscov
vaccin
develop
current
vaccin
antivir
therapeut
merscov
number
candid
merscov
vaccin
includ
base
recombin
viru
viral
vector
eg
mva
adenoviru
measl
viru
nanoparticl
dna
dnaprotein
well
subunit
vaccin
develop
none
approv
thu
need
remain
effect
broadspectrum
vaccin
merscov
infect
formerli
known
simian
viru
nonseg
negativestrand
rna
viru
nnsv
member
rubulaviru
genu
famili
paramyxovirida
includ
mump
viru
muv
human
parainfluenza
viru
type
type
encod
eight
known
viral
protein
nucleocapsid
protein
np
phosphoprotein
p
larg
rna
polymeras
l
protein
import
transcript
replic
viral
rna
genom
excel
viral
vector
candid
vaccin
develop
safe
infect
larg
number
mammal
without
associ
diseas
except
kennel
cough
dog
dna
phase
life
cycl
use
avoid
possibl
unintend
consequ
genet
modif
host
cell
dna
recombin
insert
comparison
positivestrand
rna
virus
genom
structur
stabl
recombin
express
f
respiratori
syncyti
viru
rsv
gener
f
gene
maintain
gener
grown
pfuml
indic
potenti
costeffect
safe
vaccin
vector
may
use
mass
product
discov
influenza
respiratori
syncyti
viru
rsv
rabi
vaccin
efficaci
studi
influenza
previous
report
vector
express
influenza
viru
na
provid
steril
immun
mortal
morbid
viru
detect
lung
challeng
mice
day
postchalleng
express
np
protect
mice
lethal
influenza
viru
challeng
mice
demonstr
excel
vector
develop
vaccin
respiratori
pathogen
investig
util
vaccin
express
mer
protein
robust
human
mous
model
lethal
merscov
infect
construct
vector
express
merscov
spike
glycoprotein
previous
insert
ha
gene
influenza
viru
differ
locat
within
genom
found
insert
sh
hn
gener
best
immun
respons
thu
insert
fulllength
gene
mer
sh
hn
junction
plasmid
contain
fulllength
cdna
gene
insert
sh
hn
junction
construct
use
standard
molecular
clone
techniqu
fig
plasmid
transfect
bhk
cell
along
plasmid
express
rna
polymeras
np
p
l
infecti
viru
rescu
describ
rescu
viru
plaquepurifi
expand
larg
quantiti
mdbk
cell
analysi
viral
genom
sequenc
confirm
contain
desir
input
dna
sequenc
verifi
protein
express
cell
cell
infect
differ
moi
lyse
immunoblot
use
anti
antibodi
fulllength
cleav
fragment
observ
cell
suggest
protein
properli
process
fig
express
protein
cell
confirm
immunofluoresc
assay
fig
interestingli
caus
massiv
syncytium
format
vero
cell
similar
growth
kinet
wildtyp
fig
determin
whether
gener
immun
respons
mice
mice
immun
singl
dose
control
viru
pfu
pfu
per
mous
via
intranas
rout
dose
gener
antibodi
respons
neutral
titer
modest
dose
respect
fig
b
known
balbc
mice
gener
immun
respons
respect
follow
immun
singl
dose
pfu
result
neutral
antibodi
titer
high
balbc
mice
fig
consist
respons
balbc
mice
assess
primari
cell
respons
gener
immun
mice
intranas
immun
pfu
four
week
later
lung
harvest
examin
merscovspecif
lungresid
cell
fig
shown
fig
observ
signific
increas
immun
express
merscov
spike
percentag
total
number
cell
lung
mice
comparison
infect
viru
consist
merssspecif
primari
cell
respons
lung
examin
recal
respons
merssspecif
cell
challeng
mice
pfu
merscov
result
show
signific
increas
recal
cell
respons
day
pi
comparison
mice
fig
g
also
observ
increas
merssspecif
cell
compar
primari
cell
respons
fig
g
collect
result
indic
merss
immun
induc
significantli
increas
merssspecif
cell
respons
upon
immun
determin
efficaci
prevent
modifi
merscov
infect
ki
mice
background
immun
pfu
via
intranas
rout
week
immun
mice
challeng
mouseadapt
merss
strain
fig
mice
surviv
lethal
challeng
lost
littl
weight
fig
c
contrast
pbsimmun
mice
die
follow
challeng
fig
c
indic
complet
protect
mice
lethal
challeng
mice
higher
rate
viru
clearanc
lung
provid
steril
immun
fig
histopatholog
lung
tissu
histopatholog
studi
lung
challeng
mer
indic
mice
significantli
less
cellular
debri
present
greater
mononuclear
infiltr
fig
b
mice
exhibit
robust
cellular
infiltr
leukocyt
mostli
mononuclear
cell
less
evid
lesion
edema
hyalin
membran
necrot
cellular
debri
etc
indic
sever
diseas
fig
investig
protect
respons
elicit
inactiv
merscov
ki
mice
immun
pfu
pb
via
uvinactiv
merscov
adjuv
via
im
rout
provid
protect
lethal
challeng
inactiv
merscov
protect
mice
mortal
fig
report
mice
immun
inactiv
sarscov
merscov
develop
hypersensitivitytyp
respons
respect
sarscov
merscov
challeng
manifest
increas
express
influx
eosinophil
examin
lung
mice
immun
challeng
merscov
fig
observ
eosinophil
lung
mice
immun
inactiv
merscov
pbsor
mice
follow
merscov
challeng
compar
pb
perivascular
eosinophil
infiltr
significantli
increas
inactiv
merscov
group
statist
differ
seen
mani
strategi
consid
develop
vaccin
sarscov
merscov
live
attenu
sarscov
ration
introduc
mutat
efficaci
golden
syrian
hamster
howev
develop
live
attenu
vaccin
positivestrand
rna
viru
like
sarscov
often
hamper
safeti
concern
sever
mer
vaccin
candid
investig
dnabas
vaccin
express
fulllength
protein
advanc
date
well
toler
human
shown
phase
clinic
trial
primeboost
regimen
mva
modifi
vaccinia
ankara
express
mer
protein
induc
neutral
antibodi
cell
respons
mice
limit
viral
replic
challeng
mice
camel
howev
mva
provid
steril
immun
immun
express
merscov
spike
infecti
merscov
genom
rna
detect
challeng
mice
camel
primeboost
regimen
measl
viru
mv
express
mer
solubl
induc
humor
cellular
immun
respons
mer
challeng
infecti
merscov
genom
rna
significantli
decreas
two
vaccin
provid
steril
immun
sign
inflamm
observ
mous
lung
tissu
inactiv
rabi
viru
rabv
express
mer
provid
complet
protect
mer
challeng
mice
three
dose
vaccin
need
furthermor
mous
model
use
studi
limit
adenoviru
express
mer
also
induc
neutral
antibodi
mice
enter
adenoviru
may
induc
enhanc
mucos
immun
administ
via
oral
intragastr
ig
rout
howev
ig
immun
fail
gener
mucos
immun
although
induc
humor
immun
serum
significantli
less
chimpanze
adenovirusbas
vector
system
also
use
work
demonstr
singl
dose
low
pfu
suffici
provid
protect
lethal
merscov
challeng
low
dose
especi
advantag
situat
mass
immun
program
need
short
period
time
best
knowledg
efficaci
merscov
vaccin
test
relev
anim
model
protect
mechan
vaccin
mice
like
due
robust
cellular
immun
respons
immun
neutral
antibodi
gener
mice
singledos
immun
titer
modest
pfu
pfu
respect
fig
b
consist
protect
cellular
immun
respons
protect
mice
signific
influx
cell
detect
lung
mice
follow
immun
fig
furthermor
observ
mice
higher
rate
mer
viru
clearanc
fig
suggest
role
cellbas
immun
protect
mice
lethal
challeng
interestingli
balbc
mice
gener
neutral
antibodi
titer
high
fig
possibl
higher
neutral
antibodi
titer
balbc
mice
may
protect
unfortun
avail
small
anim
model
human
mous
model
background
known
protein
major
protect
antigen
coronavirus
may
possibl
improv
vaccin
efficaci
express
addit
merscov
protein
n
use
vector
howev
parainfluenza
viru
base
sarscov
vaccin
candid
express
n
e
without
protein
fail
protect
hamster
sarscov
challeng
abil
gener
cellular
humor
immun
respons
mice
may
part
attribut
abil
express
mer
protein
nativ
conform
shown
fig
caus
massiv
syncytium
format
vero
cell
indic
protein
function
promot
celltocel
fusion
thu
reason
protein
produc
cell
maintain
nativ
conform
mer
protein
amino
acid
residu
entir
insert
gene
proper
regulatori
sequenc
nucleotid
length
longest
singl
gene
insert
genom
sinc
insert
gene
sh
hn
sh
gene
essenti
may
possibl
remov
sh
allow
insert
longer
sequenc
thu
specul
genom
accommod
sequenc
longer
nucleotid
report
inactiv
sarscovimmun
mice
gener
hypersensitivetyp
lung
patholog
viru
challeng
rais
concern
vaccineenhanc
diseas
previous
formalininactiv
wholeviru
respiratori
syncyti
viru
rsv
vaccin
caus
enhanc
diseas
vaccin
children
lead
vaccinerel
death
similarli
inactiv
merscov
report
gener
immunopatholog
merscov
challeng
mice
case
rsv
vaccin
extens
studi
indic
rsv
vaccin
caus
enhanc
diseas
thu
viral
vector
known
caus
enhanc
diseas
experi
observ
abnorm
immun
respons
mice
merscov
challeng
suggest
unlik
associ
enhanc
diseas
immun
express
merscov
spike
lung
tissu
mice
immun
inactiv
merscov
influx
eosinophil
merscov
challeng
indic
hypersensitivitytyp
respons
result
consist
previou
report
inactiv
merscov
immun
caus
increas
express
influx
eosinophil
lung
challeng
understand
whether
immun
inactiv
merscov
caus
enhanc
diseas
critic
develop
safe
effect
vaccin
merscov
high
morbid
mortal
low
preval
human
popul
dromedari
camel
consid
intermedi
host
transmit
merscov
human
thu
may
possibl
control
spread
merscov
human
control
infect
dromedari
camel
perhap
viru
transmiss
camel
human
block
concomit
immun
highrisk
human
popul
propos
cepi
coalit
epidem
prepared
innov
vaccin
vector
effect
mice
cotton
rat
hamster
guinea
pig
ferret
dog
nonhuman
primat
worthwhil
test
camel
futur
recent
identifi
wuhan
china
late
novel
zoonot
cov
relat
sarscov
caus
sever
respiratori
diseas
date
viru
result
signific
diseas
burden
case
report
countri
estim
case
fatal
rate
find
express
mer
protect
mice
lethal
merscov
challeng
singl
low
dose
pfu
suggest
potenti
use
vaccin
vector
emerg
virus
studi
use
express
protein
vaccin
candid
ongo
cell
vero
cell
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
iuml
penicillin
gml
streptomycin
ps
mediatech
inc
manassa
va
usa
cell
maintain
dmem
contain
tryptos
phosphat
broth
tpb
fetal
bovin
serum
fb
iuml
penicillin
gml
streptomycin
mdbk
cell
grown
dmem
contain
fb
ps
cell
prepar
day
prior
infect
achiev
approxim
confluenc
follow
day
virus
plasmid
contain
cdna
clone
merss
insert
sh
hn
construct
use
previous
describ
method
primer
sequenc
avail
upon
request
infecti
viru
rescu
bhk
cell
previous
describ
recombin
propag
mdbk
cell
previous
describ
plaqu
assay
perform
previous
describ
briefli
serial
dilut
prepar
dmem
bsa
one
hundr
microlit
dilut
transfer
plate
cell
total
infect
volum
ml
adsorpt
h
co
inocula
aspir
cell
monolay
overlaid
dmem
contain
tryptos
phosphat
broth
tpb
fb
ps
lowmeltingpoint
agaros
day
cell
fix
formaldehyd
overlay
remov
cell
stain
crystal
violet
visual
plaqu
obtain
viru
titer
lung
tissu
lung
infect
mice
remov
indic
day
challeng
homogen
pb
use
manual
homogen
viru
titer
determin
vero
cell
plaqu
assay
infect
vero
cell
fix
formaldehyd
stain
crystal
violet
delin
plaqu
determin
growth
rate
mdbk
cell
infect
moi
adsorpt
h
co
dmem
fb
ps
ad
plate
onehundredmicrolit
sampl
supernat
collect
daili
day
frozen
viru
titer
sampl
quantifi
plaqu
assay
immun
infect
mice
specificpathogenfre
balbc
mice
purchas
charl
river
laboratori
cr
specificpathogenfre
human
knockin
ki
mice
gener
background
previous
report
mice
bred
maintain
univers
iowa
anim
care
facil
protocol
review
approv
univers
iowa
institut
anim
care
use
committe
sixto
male
femal
mice
use
studi
mouseadapt
merscov
strain
mer
gener
report
earlier
mice
anesthet
xylazineketamin
mgkg
bodi
weight
mgkg
xylazin
infect
intranas
pfu
pfu
l
dmem
mouseadapt
mer
strain
inactiv
exposur
uv
light
h
use
wattag
wcm
pfu
uvinactiv
virus
volvol
mix
imject
alum
thermo
catalog
deliv
mice
intramuscularli
four
week
postimmun
mice
infect
intranas
pfu
mer
l
dmem
passiv
immun
sera
collect
ki
mice
receiv
pfu
intranas
week
postimmun
two
hundr
microlit
sera
transfer
ki
mice
intraperiton
day
challeng
pfu
mer
infect
mice
examin
daili
weight
record
work
merscov
perform
biosafeti
level
laboratori
univers
iowa
immun
express
merscov
spike
histolog
indic
day
postchalleng
mice
anesthet
perfus
pb
intracardiac
inject
follow
perfus
zinc
formalin
lung
remov
fix
zinc
formalin
overnight
paraffin
embed
lung
section
thick
stain
hematoxylin
eosin
tissu
evalu
boardcertifi
veterinari
pathologist
score
use
postexamin
mask
method
lung
score
edema
hyalin
membran
cellular
debri
hemorrhag
score
repres
detect
less
lung
field
respect
lung
score
mononuclear
infiltr
score
repres
valu
within
normal
paramet
repres
small
aggreg
peribronchi
perivascular
area
repres
perivascular
periairway
aggreg
fill
perivascular
space
repres
score
plu
expand
sheet
infiltr
septa
consolid
lesion
region
lung
respect
lung
score
granulocyt
infiltr
score
follow
within
normal
paramet
scatter
pmn
sequest
septa
score
plu
solitari
pmn
extravas
airspac
score
plu
small
aggreg
vessel
airspac
respect
lung
tissu
evalu
perivascular
eosinophil
infiltr
briefli
vessel
cellular
infiltr
n
randomli
select
mask
pathologist
number
eosinophil
enumer
averag
final
score
lung
neutral
antibodi
assay
four
week
postimmun
sera
immun
mice
collect
serum
sampl
heat
inactiv
incub
min
heatinactiv
serum
serial
dilut
plate
volum
merscov
pseudoviru
ad
incub
h
mixtur
ad
vero
cell
plate
incub
h
allow
viru
bind
mixtur
remov
cell
rins
pb
next
day
neutral
result
measur
luciferas
assay
plot
rel
valu
serumfre
well
immunoblot
immunofluoresc
vero
cell
infect
differ
moi
mock
infect
h
cell
lysat
collect
day
postinfect
appli
western
blot
express
merscov
spike
protein
detect
rabbit
antimerscov
antibodi
sino
biolog
catalog
coloc
use
mous
antibodi
sigma
catalog
indirect
immunofluoresc
assay
perform
detect
express
protein
cell
vero
cell
infect
fortyeight
hour
later
cell
fix
formaldehyd
phosphatebuff
salin
pb
permeabil
ad
saponin
immunostain
buffer
antimerss
sino
biolog
use
catalog
cell
imag
use
nikon
confoc
microscop
analys
merscovspecif
cell
respons
ki
mice
immun
pfu
via
intranas
rout
week
postimmun
lung
cell
harvest
merscovspecif
cell
stimul
peptid
describ
previous
presenc
golgiplug
lml
h
cell
wash
stain
cell
surfac
marker
follow
intracellular
ifngamma
stain
examin
recal
cell
respons
ki
mice
immun
pfu
via
intranas
rout
challeng
pfu
mer
four
day
mer
infect
lung
harvest
cell
stimul
peptid
presenc
golgiplug
lml
h
cell
wash
stain
cell
surfac
marker
follow
intracellular
ifngamma
stain
follow
monoclon
antibodi
use
bd
bioscienc
ebiosci
